BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32507053)

  • 1. Return-to-Function Following Treatment of Dupuytren Contracture With Collagenase Clostridium Histolyticum Versus Fasciectomy.
    Divino VM; DeKoven M; Hurley D
    Hand (N Y); 2022 May; 17(3):491-498. PubMed ID: 32507053
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient Preferences for Limited Fasciectomy Versus Collagenase Treatment for Dupuytren Contracture.
    Zhang D; Blazar P; Benavent KA; Earp BE
    J Hand Surg Asian Pac Vol; 2022 Apr; 27(2):242-247. PubMed ID: 35404200
    [No Abstract]   [Full Text] [Related]  

  • 3. Limited Fasciectomy Versus Collagenase Clostridium histolyticum for Dupuytren Contracture: A Propensity Score Matched Study of Single Digit Treatment With Minimum 5 Years of Telephone Follow-Up.
    Gruber JS; Zhang D; Janssen SJ; Blazar P; Jupiter JB; Earp BE
    J Hand Surg Am; 2021 Oct; 46(10):888-895. PubMed ID: 34275684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupuytren's Contracture Recurrence and Treatment Following Collagenase Clostridium Histolyticum Injection: A Longitudinal Assessment in a Veteran Population.
    Zarb RM; Graf AR; Talhelm JE; Stehr RC; Sanger JR; Matloub HS; Daley RA
    Mil Med; 2023 Aug; 188(9-10):e2975-e2981. PubMed ID: 36928340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis.
    Zah V; Pelivanovic J; Tatovic S; Vukicevic D; Imro M; Ruby J; Hurley D
    Clinicoecon Outcomes Res; 2020; 12():635-643. PubMed ID: 33177851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Range of motion, postoperative rehabilitation and patient satisfaction in MCP and PIP joints affected by Dupuytren Tubiana stage 1-3: collagenase enzymatic fasciotomy or limited fasciectomy? A clinical study in 52 patients.
    Leclère FM; Kohl S; Varonier C; Unglaub F; Vögelin E
    Arch Orthop Trauma Surg; 2018 Nov; 138(11):1623-1631. PubMed ID: 30259125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacies and limitations of fasciectomy and collagenase clostridium histolyticum in Dupuytren's contracture management: A meta-analysis.
    Cooper TB; Poonit K; Yao C; Jin Z; Zheng J; Yan H
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020921747. PubMed ID: 32484064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren's contracture.
    Peimer CA; Wilbrand S; Gerber RA; Chapman D; Szczypa PP
    J Hand Surg Eur Vol; 2015 Feb; 40(2):141-9. PubMed ID: 24698851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
    Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
    J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture.
    Räisänen MP; Karjalainen T; Göransson H; Reito A; Kautiainen H; Malmivaara A; Leppänen OV
    BMJ Open; 2018 Mar; 8(3):e019054. PubMed ID: 29599391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 10-Year Review of Collagenase Versus Fasciectomy in the Treatment of Dupuytren Contracture.
    Steppe C; Cinclair R; Lies S
    Ann Plast Surg; 2024 Jun; 92(6):642-646. PubMed ID: 38717148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of resources and costs associated with the treatment of Dupuytren's contracture at an orthopedics and traumatology surgery department in Denia (Spain): collagenase clostridium hystolyticum versus subtotal fasciectomy.
    Sanjuan Cerveró R; Franco Ferrando N; Poquet Jornet J
    BMC Musculoskelet Disord; 2013 Oct; 14():293. PubMed ID: 24125161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagenase Clostridium Histolyticum versus Limited Fasciectomy for Dupuytren's Contracture: Outcomes from a Multicenter Propensity Score Matched Study.
    Zhou C; Hovius SER; Slijper HP; Feitz R; Van Nieuwenhoven CA; Pieters AJ; Selles RW
    Plast Reconstr Surg; 2015 Jul; 136(1):87-97. PubMed ID: 25829153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Collagenase Clostridium histolyticum Introduction on Dupuytren Treatment Patterns in the United States.
    Zhao JZ; Hadley S; Floyd E; Earp BE; Blazar PE
    J Hand Surg Am; 2016 Oct; 41(10):963-968. PubMed ID: 27546441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagenase clostridium histolyticum injection versus limited fasciectomy for the treatment of Dupuytren's disease: a systematic review and meta-analysis of comparative studies.
    Liechti R; Merky DN; Sutter D; Ipaktchi R; Vögelin E
    Arch Orthop Trauma Surg; 2024 Jan; 144(1):527-536. PubMed ID: 37665353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent Dupuytren's disease after fasciectomy and collagenase injection are histologically indistinguishable.
    Sanjuan-Cervero R; Carrera-Hueso FJ; Vaquero-Perez M; Montaner-Alonso D
    J Hand Surg Eur Vol; 2020 Jun; 45(5):508-512. PubMed ID: 31980000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost Comparison of Collagenase Clostridium Histolyticum and Fasciectomy for Treatment of Dupuytren's Contracture in the Australian Health System.
    Sefton AK; Smith BJ; Stewart DA
    J Hand Surg Asian Pac Vol; 2018 Sep; 23(3):336-341. PubMed ID: 30282551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A
    Pess GM; Sundbom M; Wilson K; Lindqvist D; Dahlin LB
    J Plast Surg Hand Surg; 2018 Oct; 52(5):301-306. PubMed ID: 30039732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage palmar fasciectomy after initial treatment with collagenase clostridium histolyticum.
    Eberlin KR; Kobraei EM; Nyame TT; Bloom JM; Upton J
    Plast Reconstr Surg; 2015 Jun; 135(6):1000e-1006e. PubMed ID: 26017606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term recurrence of Dupuytren's disease treated with clostridium histolitycum collagenase. Surgical treatment and anatomopathological study.
    Simón-Pérez C; Rodríguez-Mateos JI; Maestro IA; Alvarez-Quiñones M; Simon-Perez E; Martín-Ferrero MA
    Arch Orthop Trauma Surg; 2024 May; 144(5):2085-2091. PubMed ID: 38653835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.